Infinitopes Limited

Infinitopes is aiming to combat cancer through a novel vaccine platform integrated with an industry leading tumour antigen discovery technology.

Infinitopes is a Cancer Research UK (CRUK) and Oxford University-supported team of doctors and scientists with expertise across oncology, immunology, antigen discovery, vaccinology and biomanufacturing. Infinitopes is pushing the boundaries of science and medicine to identify hidden tumour targets that enable them to create high-efficiency cancer vaccines addressing unmet clinical needs. One of Infinitopes' key goals is also to ensure that its novel vaccine platform remains affordable to the healthcare systems and patients. Infinitopes are always looking for high-calibre new hires and collaborators, and are honoured to learn from healthcare professionals and patients, to improve their therapy designs.

• Immunology/inflammation
• Engineered Biology
• Platform Technology
• Oncology
• Translational Medicine
• Biomarkers